Depletion of the RNA binding protein HNRNPD impairs homologous recombination by inhibiting DNA-end resection and inducing R-loop accumulation.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
07 05 2019
Historique:
accepted: 01 02 2019
revised: 24 01 2019
received: 08 08 2018
pubmed: 26 2 2019
medline: 26 11 2019
entrez: 26 2 2019
Statut: ppublish

Résumé

DNA double strand break (DSB) repair through homologous recombination (HR) is crucial to maintain genome stability. DSB resection generates a single strand DNA intermediate, which is crucial for the HR process. We used a synthetic DNA structure, mimicking a resection intermediate, as a bait to identify proteins involved in this process. Among these, LC/MS analysis identified the RNA binding protein, HNRNPD. We found that HNRNPD binds chromatin, although this binding occurred independently of DNA damage. However, upon damage, HNRNPD re-localized to γH2Ax foci and its silencing impaired CHK1 S345 phosphorylation and the DNA end resection process. Indeed, HNRNPD silencing reduced: the ssDNA fraction upon camptothecin treatment; AsiSI-induced DSB resection; and RPA32 S4/8 phosphorylation. CRISPR/Cas9-mediated HNRNPD knockout impaired in vitro DNA resection and sensitized cells to camptothecin and olaparib treatment. We found that HNRNPD interacts with the heterogeneous nuclear ribonucleoprotein SAF-A previously associated with DNA damage repair. HNRNPD depletion resulted in an increased amount of RNA:DNA hybrids upon DNA damage. Both the expression of RNase H1 and RNA pol II inhibition recovered the ability to phosphorylate RPA32 S4/8 in HNRNPD knockout cells upon DNA damage, suggesting that RNA:DNA hybrid resolution likely rescues the defective DNA damage response of HNRNPD-depleted cells.

Identifiants

pubmed: 30799487
pii: 5364135
doi: 10.1093/nar/gkz076
pmc: PMC6486545
doi:

Substances chimiques

Antineoplastic Agents 0
Chromatin 0
DNA, Single-Stranded 0
H2AX protein, human 0
HNRNPD protein, human 0
HNRNPU protein, human 0
Heterogeneous Nuclear Ribonucleoprotein D0 0
Heterogeneous-Nuclear Ribonucleoprotein D 0
Heterogeneous-Nuclear Ribonucleoprotein U 0
Histones 0
Phthalazines 0
Piperazines 0
RNA, Small Interfering 0
Replication Protein A 0
DNA 9007-49-2
CHEK1 protein, human EC 2.7.11.1
Checkpoint Kinase 1 EC 2.7.11.1
RNA Polymerase II EC 2.7.7.-
RPA2 protein, human EC 2.7.7.7
Ribonuclease H EC 3.1.26.4
ribonuclease HI EC 3.1.26.4
olaparib WOH1JD9AR8
Camptothecin XT3Z54Z28A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4068-4085

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Methods Mol Biol. 2006;314:123-31
pubmed: 16673879
Nature. 2007 Nov 22;450(7169):509-14
pubmed: 17965729
DNA Repair (Amst). 2014 Jul;19:84-94
pubmed: 24746923
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
EMBO J. 2008 Jul 9;27(13):1875-85
pubmed: 18511906
EMBO Rep. 2009 Aug;10(8):887-93
pubmed: 19557000
Int J Cell Biol. 2013;2013:153634
pubmed: 24159334
Nucleic Acids Res. 2008 Oct;36(17):5678-94
pubmed: 18772227
EMBO J. 2010 Apr 21;29(8):1446-57
pubmed: 20360682
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Nat Commun. 2015 Jul 28;6:7744
pubmed: 26215093
Nucleic Acids Res. 2013 Oct;41(19):9117-28
pubmed: 23935072
J Biol Chem. 1994 Apr 15;269(15):11121-32
pubmed: 8157639
Mol Cell. 2013 May 23;50(4):589-600
pubmed: 23706822
Mol Cell. 2007 Jan 12;25(1):71-83
pubmed: 17218272
Cytometry A. 2012 Oct;81(10):922-8
pubmed: 22893507
Cell Rep. 2018 May 8;23(6):1891-1905
pubmed: 29742442
Nature. 2000 Jun 8;405(6787):697-700
pubmed: 10864328
Annu Rev Biochem. 2008;77:229-57
pubmed: 18275380
J Biol Chem. 2015 Sep 18;290(38):22931-8
pubmed: 26231213
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Mol Oncol. 2011 Aug;5(4):387-93
pubmed: 21821475
J Biol Chem. 2010 Dec 31;285(53):41993-2000
pubmed: 20929861
Genes Dev. 2011 Feb 15;25(4):350-62
pubmed: 21325134
J Biol Chem. 2008 Jan 4;283(1):1-5
pubmed: 17999957
Int J Mol Sci. 2016 Feb 27;17(3):310
pubmed: 26927092
Mol Cell. 2012 Jul 13;47(1):5-15
pubmed: 22633954
Cancer Res. 2006 Aug 15;66(16):8109-15
pubmed: 16912188
Nat Rev Mol Cell Biol. 2014 Nov;15(11):749-60
pubmed: 25269475
Mol Cell Biol. 2008 May;28(9):3058-69
pubmed: 18285453
Genes Dev. 2014 Jul 1;28(13):1384-96
pubmed: 24990962
Cell. 2016 Nov 3;167(4):1001-1013.e7
pubmed: 27881299
Nature. 2001 Aug 9;412(6847):607-14
pubmed: 11493912
Genes Dev. 2011 Mar 1;25(5):409-33
pubmed: 21363960
J Mol Biol. 2017 Oct 27;429(21):3132-3138
pubmed: 27452366
Nucleic Acids Res. 2016 Jul 8;44(12):5743-57
pubmed: 27131361
Genes Dev. 1999 Oct 15;13(20):2633-8
pubmed: 10541549
Bioorg Med Chem Lett. 2017 Feb 15;27(4):701-707
pubmed: 28073672
Biomaterials. 2015 Sep;63:168-76
pubmed: 26107993
Nat Protoc. 2011 Feb;6(2):134-9
pubmed: 21293454
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5779-84
pubmed: 25902524
J Biol Chem. 2003 May 30;278(22):20303-12
pubmed: 12660252
Acta Neuropathol. 2013 Mar;125(3):413-23
pubmed: 23381195
J Biol Chem. 1985 Nov 25;260(27):14873-8
pubmed: 2997227
Genes Dev. 1998 Dec 15;12(24):3831-42
pubmed: 9869637
Methods Enzymol. 2006;409:118-31
pubmed: 16793398
Nucleic Acids Res. 2014 Aug;42(14):9047-62
pubmed: 25030905
J Biol Chem. 2005 May 13;280(19):18862-70
pubmed: 15734733
Nature. 2011 Mar 24;471(7339):532-6
pubmed: 21399625
Annu Rev Genet. 2004;38:233-71
pubmed: 15568977
Carcinogenesis. 2001 Nov;22(11):1789-96
pubmed: 11698340
Mol Cell Biol. 2016 Oct 28;36(22):2794-2810
pubmed: 27550810
Wiley Interdiscip Rev RNA. 2010 Nov-Dec;1(3):457-73
pubmed: 21956942
Cell Rep. 2017 Oct 10;21(2):324-332
pubmed: 29020620
Nat Commun. 2014 Nov 04;5:5248
pubmed: 25366541
Rejuvenation Res. 2009 Jun;12(3):199-208
pubmed: 19594328
Mol Cell. 2016 Oct 6;64(1):189-198
pubmed: 27716483
Cell Rep. 2014 Oct 23;9(2):451-9
pubmed: 25310973
Clin Oncol (R Coll Radiol). 2014 May;26(5):243-9
pubmed: 24630811
Genetics. 1998 Mar;148(3):989-1005
pubmed: 9539419
Front Biosci (Landmark Ed). 2011 Jun 01;16:2307-25
pubmed: 21622178
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
Nat Rev Cancer. 2004 Oct;4(10):814-9
pubmed: 15510162
Nat Commun. 2018 Feb 7;9(1):532
pubmed: 29416038
J Biol Chem. 2009 Apr 3;284(14):9558-65
pubmed: 19202191
Crit Rev Biochem Mol Biol. 2016 May-Jun;51(3):195-212
pubmed: 27098756
Mol Cell. 2014 Jan 23;53(2):235-246
pubmed: 24332808
Mol Cell. 2012 Feb 24;45(4):505-16
pubmed: 22365830
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Mol Cell Biol. 2005 Aug;25(16):7158-69
pubmed: 16055725
Nat Cell Biol. 2016 Mar;18(3):271-280
pubmed: 26807646
J Biol Chem. 2008 Jul 4;283(27):19095-111
pubmed: 18469000
Nat Rev Mol Cell Biol. 2011 Feb;12(2):90-103
pubmed: 21252998
Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):680-8
pubmed: 23246978
Nucleic Acids Res. 2014 Feb;42(3):e19
pubmed: 24362840
Nat Rev Mol Cell Biol. 2002 Mar;3(3):195-205
pubmed: 11994740
Ann N Y Acad Sci. 2000;922:1-10
pubmed: 11193884
Nat Struct Mol Biol. 2010 Jan;17(1):11-6
pubmed: 20051983
DNA Repair (Amst). 2014 Jul;19:169-75
pubmed: 24746645
J Biol Chem. 1995 Sep 22;270(38):22167-75
pubmed: 7673195

Auteurs

Luigi Alfano (L)

Oncology Research Center of Mercogliano (CROM); Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italia.

Antonella Caporaso (A)

Department of Medical Biotechnologies, University of Siena, Siena, Italia.
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.

Angela Altieri (A)

Department of Medical Biotechnologies, University of Siena, Siena, Italia.

Milena Dell'Aquila (M)

Department of Medical Biotechnologies, University of Siena, Siena, Italia.

Claudia Landi (C)

Department of Life Sciences, University of Siena, Siena, Italia.

Luca Bini (L)

Department of Life Sciences, University of Siena, Siena, Italia.

Francesca Pentimalli (F)

Oncology Research Center of Mercogliano (CROM); Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italia.

Antonio Giordano (A)

Department of Medical Biotechnologies, University of Siena, Siena, Italia.
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH